Aerpio Therapeutics

Novel small molecules and monoclonal antibodies for the treatment of vascular disease and to enhance wound healing, specifically diabetic macular edem....

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Aerpio Therapeutics plus 5589 other startups.

Start Free 7 Day Trial Now

Learn More About Aerpio Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Companies We Work With